Blueprint Medicines Corporation
Blueprint Medicines Corporation (BPMC) on the NASDAQ Exchange
Company overview
Blueprint Medicines Corporation is a publicly listed company from USA with shares traded on NASDAQ under the ticker BPMC. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for BPMC are bid 129.12 USD and ask 129.9 USD.
Use the chart to review recent momentum, identify key price areas, and track how Blueprint Medicines Corporation is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add BPMC to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.
Key facts
- Exchange: NASDAQ
- Company: Blueprint Medicines Corporation
- Ticker: BPMC
- Country: USA
- Bid: 129.12 USD
- Ask: 129.9 USD
- Quotes: real-time, auto-updated
Risk
Risk Warning: Past performance of BPMC does not predict future returns.
FAQ
Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Blueprint Medicines Corporation (BPMC) in R StocksTrader. Create and verify your profile, fund the account, search for BPMC, and choose the instrument type available to you. Add BPMC to your Watchlist to track moves and manage open positions throughout 2025.
BPMC trades on NASDAQ and is issued by Blueprint Medicines Corporation. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for BPMC match your plan.
Quotes update automatically in real time. Current levels for BPMC are bid 129.12 USD and ask 129.9 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track BPMC in R StocksTrader and adjust your approach as market conditions change in 2025.